AnalystsMichelle GilsonMichelle Gilson's Stock Forecasts
AnalystsMichelle Gilson
Sectors:
Analyst Ranking
Bottom 6%
#4581 out of 4868 analysts
Average Return
-33.44%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good
Michelle Gilson's 5 best and worst ratings
Michelle Gilson Analyst Color
Get additional color on Michelle Gilson's coverage of popular stocks
Michelle Gilson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vir Biotechnology IncVIR | 4 | Strong Buy | $20.00 | +226.80% | Upgrades | 4 months ago |
Q32 Bio IncQTTB | 2 | Strong Buy | $126.00 | N/A | Maintains | 3 years ago |
Corcept Therapeutics IncCORT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Sigilon Therapeutics IncSGTX | 3 | Strong Buy | $91.00 | N/A | Maintains | 3 years ago |
Rezolute IncRZLT | 1 | Strong Buy | $17.00 | N/A | Maintains | 3 years ago |
Ascendis Pharma AASND | 2 | Strong Buy | $196.00 | N/A | Maintains | 4 years ago |
Travere Therapeutics IncTVTX | 1 | Strong Buy | $45.00 | N/A | Maintains | 4 years ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $76.00 | N/A | Maintains | 4 years ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $95.00 | N/A | Maintains | 5 years ago |
Amryt Pharma PLCAMYT | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.